pyrimidin-2-one beta-ribofuranoside has been researched along with T-Cell Lymphoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Desco, M; Esteller, M; Flores, JM; Fraga, MF; Herranz, M; Marquez, V; MartÃn-Caballero, J; Ruiz-Cabello, J | 1 |
1 other study(ies) available for pyrimidin-2-one beta-ribofuranoside and T-Cell Lymphoma
| Article | Year |
|---|---|
The novel DNA methylation inhibitor zebularine is effective against the development of murine T-cell lymphoma.
Topics: Animals; Antineoplastic Agents; Cell Transformation, Neoplastic; Cytidine; DNA Methylation; Drug Evaluation, Preclinical; Gene Silencing; Injections, Intraperitoneal; Lymphoma, T-Cell; Mice; Neoplasms, Experimental | 2006 |